HCPCS Level II
J9333
Injection, rozanolixizumab-noli, 1 mg
Codes near J9333
These sit next to J9333 in the CMS Level II file. All J codes
- J9328Injection, temozolomide, 1 mg
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9331Injection, sirolimus protein-bound particles, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
- J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340Injection, thiotepa, 15 mg
- J9341Injection, thiotepa (tepylute), 1 mg
- J9342Injection, thiotepa, not otherwise specified, 1 mg
- J9345Injection, retifanlimab-dlwr, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50474-0980-79 | Rystiggo | UCB, Inc. | 280 |
| 50474-0981-83 | Rystiggo | UCB, Inc. | 420 |
| 50474-0982-84 | Rystiggo | UCB, Inc. | 560 |
| 50474-0983-86 | Rystiggo | UCB, Inc. | 840 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.